Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
|
Preferred Stock [Member]
Series B Preferred Stock [Member]
|
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
|
Common Stock [Member] |
Deferred Stock Based Compensation [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Series B Preferred Stock [Member] |
Total |
Balance at Dec. 31, 2021 |
$ 2
|
|
$ 165
|
$ (900,742)
|
$ 29,765,585
|
$ (29,281,674)
|
|
$ (416,664)
|
Balance, shares at Dec. 31, 2021 |
1,509
|
|
1,652,102
|
|
|
|
|
|
Common stock issued for services |
|
|
$ 3
|
|
254,748
|
|
|
254,751
|
Common stock issused for services, shares |
|
|
28,750
|
|
|
|
|
|
Conversion of debentures |
|
|
$ 1
|
|
34,999
|
|
|
35,000
|
Conversion of debentures, shares |
|
|
5,469
|
|
|
|
|
|
Incremental value from warrant modifications |
|
|
|
|
41,225
|
(41,225)
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(7,202)
|
|
|
(7,202)
|
40:1 Reverse Split Fractional Shares Adjustment |
|
|
|
|
|
|
|
|
40:1 Reverse Split Fractional Shares Adjustment, shares |
|
|
266
|
|
|
|
|
|
Series B, preferred stock contractual dividends |
|
|
|
|
(37,206)
|
|
|
(37,206)
|
Accretion of stock-based compensation to employees and directors |
|
|
|
213,041
|
107,312
|
|
|
320,353
|
Accretion of stock-based compensation to employees and directors, shares |
|
|
|
|
|
|
|
|
Net loss period |
|
|
|
|
|
(1,788,246)
|
|
(1,788,246)
|
Balance at Mar. 31, 2022 |
$ 2
|
|
$ 169
|
(687,701)
|
30,159,461
|
(31,111,145)
|
|
(1,639,214)
|
Balance, shares at Mar. 31, 2022 |
1,509
|
|
1,686,587
|
|
|
|
|
|
Balance at Dec. 31, 2021 |
$ 2
|
|
$ 165
|
(900,742)
|
29,765,585
|
(29,281,674)
|
|
(416,664)
|
Balance, shares at Dec. 31, 2021 |
1,509
|
|
1,652,102
|
|
|
|
|
|
Net loss period |
|
|
|
|
|
|
|
$ (4,305,432)
|
Issuance of common stock for cash, shares |
|
|
|
|
|
|
|
269,775
|
Balance at Sep. 30, 2022 |
|
|
$ 193
|
(348,548)
|
31,563,286
|
(33,628,332)
|
|
$ (2,413,399)
|
Balance, shares at Sep. 30, 2022 |
1,509
|
|
1,922,143
|
|
|
|
|
|
Balance at Mar. 31, 2022 |
$ 2
|
|
$ 169
|
(687,701)
|
30,159,461
|
(31,111,145)
|
|
(1,639,214)
|
Balance, shares at Mar. 31, 2022 |
1,509
|
|
1,686,587
|
|
|
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(6,018)
|
|
|
(6,018)
|
Series B, preferred stock contractual dividends |
|
|
|
|
(38,035)
|
|
|
(38,035)
|
Accretion of stock-based compensation to employees and directors |
|
|
|
215,409
|
212,175
|
|
|
427,584
|
Net loss period |
|
|
|
|
|
(1,283,446)
|
|
(1,283,446)
|
Balance at Jun. 30, 2022 |
|
|
$ 169
|
(472,292)
|
30,327,583
|
(32,394,591)
|
|
(2,539,129)
|
Balance, shares at Jun. 30, 2022 |
1,509
|
|
1,686,587
|
|
|
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(7,200)
|
|
|
(7,200)
|
Series B, preferred stock contractual dividends |
|
|
|
|
(38,034)
|
|
|
(38,034)
|
Accretion of stock-based compensation to employees and directors |
|
|
|
217,776
|
190,961
|
|
|
408,737
|
Net loss period |
|
|
|
|
|
(1,233,741)
|
|
(1,233,741)
|
Stock-based compensation for services |
|
|
$ 3
|
(94,032)
|
164,997
|
|
|
70,968
|
Stock-based compensation for services, shares |
|
|
30,000
|
|
|
|
|
|
Sale of common stock and warrants |
|
|
$ 21
|
|
924,979
|
|
|
925,000
|
Sale of common stock and warrants, shares |
|
|
205,556
|
|
|
|
|
|
Balance at Sep. 30, 2022 |
|
|
$ 193
|
(348,548)
|
31,563,286
|
(33,628,332)
|
|
(2,413,399)
|
Balance, shares at Sep. 30, 2022 |
1,509
|
|
1,922,143
|
|
|
|
|
|
Balance at Dec. 31, 2022 |
$ 2
|
|
$ 228
|
(187,329)
|
33,428,115
|
(35,177,625)
|
|
(1,936,609)
|
Balance, shares at Dec. 31, 2022 |
1,509
|
|
2,279,019
|
|
|
|
|
|
Common stock issued for services |
|
|
$ 2
|
115,090
|
141,477
|
|
|
256,569
|
Common stock issused for services, shares |
|
|
16,500
|
|
|
|
|
|
Incremental value from warrant modifications |
|
|
|
|
282,309
|
(282,309)
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(7,200)
|
|
|
(7,200)
|
Series B, preferred stock contractual dividends |
|
|
|
|
(37,207)
|
|
|
(37,207)
|
Accretion of stock-based compensation to employees and directors |
|
|
|
36,740
|
132,593
|
|
|
169,333
|
Net loss period |
|
|
|
|
|
(1,507,042)
|
|
(1,507,042)
|
Deemed dividend from Series A conversion price adjustment |
|
|
|
|
96,245
|
(96,245)
|
|
|
Deemed dividend from Series B conversion price adjustment |
|
|
|
|
168,835
|
(168,835)
|
|
|
Issuance of common stock for cash |
|
|
$ 7
|
|
314,239
|
|
|
314,246
|
Issuance of common stock for cash, shares |
|
|
69,834
|
|
|
|
|
|
Exercise of warrants for cash to common stock |
|
|
$ 37
|
|
1,094,965
|
|
|
1,095,001
|
Exercise of warrants for cash to common stock, shares |
|
|
365,001
|
|
|
|
|
|
Conversion of convertible debt to common stock |
|
|
$ 16
|
|
519,696
|
|
|
519,712
|
Conversion of convertible debt to common stock, shares |
|
|
164,446
|
|
|
|
|
|
Inducement for conversion of convertible debt |
|
|
|
|
397,937
|
|
|
397,937
|
Balance at Mar. 31, 2023 |
$ 2
|
|
$ 290
|
(35,499)
|
36,532,003
|
(37,232,056)
|
|
(735,260)
|
Balance, shares at Mar. 31, 2023 |
1,509
|
|
2,894,800
|
|
|
|
|
|
Balance at Dec. 31, 2022 |
$ 2
|
|
$ 228
|
(187,329)
|
33,428,115
|
(35,177,625)
|
|
(1,936,609)
|
Balance, shares at Dec. 31, 2022 |
1,509
|
|
2,279,019
|
|
|
|
|
|
Net loss period |
|
|
|
|
|
|
|
$ (3,909,216)
|
Issuance of common stock for cash |
|
|
|
|
|
|
$ 642,018
|
|
Issuance of common stock for cash, shares |
|
|
|
|
|
|
|
1,191,792
|
Balance at Sep. 30, 2023 |
$ 2
|
|
$ 347
|
(1,391,259)
|
39,222,671
|
(39,674,693)
|
|
$ (1,842,932)
|
Balance, shares at Sep. 30, 2023 |
1,509
|
|
3,470,811
|
|
|
|
|
|
Balance at Mar. 31, 2023 |
$ 2
|
|
$ 290
|
(35,499)
|
36,532,003
|
(37,232,056)
|
|
(735,260)
|
Balance, shares at Mar. 31, 2023 |
1,509
|
|
2,894,800
|
|
|
|
|
|
Common stock issued for services |
|
|
$ 7
|
(78,875)
|
323,482
|
|
|
244,614
|
Common stock issused for services, shares |
|
|
76,000
|
|
|
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(7,200)
|
|
|
(7,200)
|
Series B, preferred stock contractual dividends |
|
|
|
|
(37,620)
|
|
|
(37,620)
|
Accretion of stock-based compensation to employees and directors |
|
|
$ 27
|
(1,345,510)
|
1,467,953
|
|
|
122,470
|
Accretion of stock-based compensation to employees and directors, shares |
|
|
271,141
|
|
|
|
|
|
Net loss period |
|
|
|
|
|
(1,237,882)
|
|
(1,237,882)
|
Balance at Jun. 30, 2023 |
$ 2
|
|
$ 324
|
(1,459,884)
|
38,278,618
|
(38,469,938)
|
|
(1,650,878)
|
Balance, shares at Jun. 30, 2023 |
1,509
|
|
3,241,941
|
|
|
|
|
|
Common stock issued for services |
|
|
$ 5
|
68,625
|
235,366
|
|
|
303,996
|
Common stock issused for services, shares |
|
|
52,400
|
|
|
|
|
|
Series A, preferred stock contractual dividends |
|
|
|
|
(7,200)
|
|
|
(7,200)
|
Series B, preferred stock contractual dividends |
|
|
|
|
(38,034)
|
|
|
(38,034)
|
Accretion of stock-based compensation to employees and directors |
|
|
|
|
113,478
|
|
|
113,478
|
Net loss period |
|
|
|
|
|
(1,164,294)
|
|
(1,164,294)
|
Issuance of common stock for cash |
|
|
$ 18
|
|
599,982
|
|
|
600,000
|
Issuance of common stock for cash, shares |
|
|
176,470
|
|
|
|
|
|
Balance at Sep. 30, 2023 |
$ 2
|
|
$ 347
|
$ (1,391,259)
|
$ 39,222,671
|
$ (39,674,693)
|
|
$ (1,842,932)
|
Balance, shares at Sep. 30, 2023 |
1,509
|
|
3,470,811
|
|
|
|
|
|